15 There are 31 secondary endpoints, including, achievement of 10, 15%, and 20% body weight reduction, and absolute changes from baseline to Week 76 in: 15 Body weight Waist circumference Blood pressure Body Mass Index (BMI) Glycosylated hemoglobin A1c (HbA1c) Total cholesterol Liver fat content Body composition sub study endpoints included absolute and relative change in: Total fat volume Lean body volume Visceral fat volume Subcutaneous fat volume About the SYNCHRONIZE-MASLD trial (NCT06309992) This is a Phase III, double-blind, placebo-controlled 48-week efficacy and safety trial of survodutide among 218 adults living with obesity and overweight and with MASLD with evidence of inflammation and or fibrosis versus placebo

Benefits that make a difference Physical performance Hormone balance Energy levels Mental focus Fast & discreet shipping Care for energy, hormones, and performance Mens healthcare, built for men who expect more Care designed to help you feel stronger, sharper, and more in control Doctor-guided care for hormones, energy, and performance, with treatment plans tailored to your goals and adjusted as your body responds
Aligned reads were quantified at the gene level using an expectation maximization method (RSEM) and gene counts were combined across samples into a sample-by-gene count matrix
Availability : Available and licensed in SA